Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,149
  • Shares Outstanding, K 41,216
  • Annual Sales, $ 5,640 K
  • Annual Income, $ -23,880 K
  • 60-Month Beta 1.49
  • Price/Sales 4.89
  • Price/Cash Flow N/A
  • Price/Book 0.95
Trade EVGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings $-0.13 on 03/07/24
  • Latest Earnings Date 05/16/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 429.27% ( +429.27%)
  • Historical Volatility 60.07%
  • IV Percentile 66%
  • IV Rank 31.75%
  • IV High 1,272.65% on 08/15/23
  • IV Low 36.90% on 05/17/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 989
  • Open Int (30-Day) 1,159

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6120 +2.14%
on 04/19/24
0.8611 -27.41%
on 04/08/24
-0.1050 (-14.38%)
since 03/26/24
3-Month
0.6120 +2.14%
on 04/19/24
1.0400 -39.89%
on 03/04/24
-0.0749 (-10.70%)
since 01/26/24
52-Week
0.4502 +38.85%
on 10/24/23
1.4400 -56.59%
on 07/13/23
+0.0551 (+9.67%)
since 04/26/23

Most Recent Stories

More News
Evogene Provides Operational Update Amidst Current Security Situation in Israel

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 0.6251 (-5.10%)
Casterra Delivers First Shipment of Castor Seeds to Africa

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN)...

EVGN : 0.6251 (-5.10%)
Evogene Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...

EVGN : 0.6251 (-5.10%)
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 0.6251 (-5.10%)
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering

/PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based...

EVGN : 0.6251 (-5.10%)
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience

/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and a leading ag-biologicals company that develops microbiome-based,...

EVGN : 0.6251 (-5.10%)
CTVA : 54.92 (+0.40%)
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (NASDAQ: EVGN)...

EVGN : 0.6251 (-5.10%)
Lavie Bio Receives Canadian Regulatory Approval for Thrivusâ„¢, Expanding Global Reach

/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biological company focusing on improving food...

EVGN : 0.6251 (-5.10%)
Evogene Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...

EVGN : 0.6251 (-5.10%)
BioCardia, Inc. (BCDA) Reports Q1 Loss, Misses Revenue Estimates

BioCardia, Inc. (BCDA) delivered earnings and revenue surprises of -30.77% and 81.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BCDA : 0.3766 (+2.34%)
EVGN : 0.6251 (-5.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene...

See More

Key Turning Points

3rd Resistance Point 0.7107
2nd Resistance Point 0.6904
1st Resistance Point 0.6577
Last Price 0.6251
1st Support Level 0.6047
2nd Support Level 0.5844
3rd Support Level 0.5517

See More

52-Week High 1.4400
Fibonacci 61.8% 1.0619
Fibonacci 50% 0.9451
Fibonacci 38.2% 0.8283
Last Price 0.6251
52-Week Low 0.4502

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar